Core Laboratories
CLB
372 hedge funds and large institutions have $5.57B invested in Core Laboratories in 2016 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 118 increasing their positions, 135 reducing their positions, and 48 closing their positions.
106% more call options, than puts
Call options by funds: $35.4M | Put options by funds: $17.1M
15% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 48
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
10% more capital invested
Capital invested by funds: $5.08B → $5.57B (+$484M)
2.59% more ownership
Funds ownership: 102.68% → 105.26% (+2.6%)
0% more funds holding
Funds holding: 372 → 372 (0)
13% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 135
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$106M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$47.8M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$45.4M |
| 4 |
JP Morgan Chase
New York
|
+$40.5M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$28.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bessemer Group
Woodbridge,
New Jersey
|
-$60.2M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$60.1M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$38.5M |
| 4 |
WP
Wedgewood Partners
St Louis,
Missouri
|
-$27.3M |
| 5 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$27.2M |
CLB Hedge Fund Activity: Q4 2016 in Review
372 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2016, worth a combined $5.57B — up 9.5% from $5.08B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new CLB positions and 48 closed out — a net gain of 7 holders — while 118 added to existing stakes and 135 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $106M. The largest seller was Bessemer Group, cutting an estimated $60.2M.
- 372 institutional investors held Core Laboratories (CLB) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $5.57B of Core Laboratories stock for Q4 2016, up 9.5% quarter-over-quarter.
- 55 funds opened new Core Laboratories positions in Q4 2016 and 48 closed out, a net change of +7 holders.
- The largest Core Laboratories buyer in Q4 2016 was Capital World Investors, an estimated $106M added.
- The largest Core Laboratories seller in Q4 2016 was Bessemer Group, an estimated $60.2M sold.
Based on aggregated 13F filings for Q4 2016.